| Name | Title | Contact Details |
|---|
Robertson GMC Truck Inc is a company based out of 2680 Cranberry Hwy, Wareham, Massachusetts, United States.
AI REV is a boutique AI consulting company with partners having extensive practical AI experience and strong track records. We provide state-of-the-art consulting & AI project delivery for enterprise clients. AI REVs goal is to reduce the average human workweek from 40 hours to 20. We are working towards achieving this by augmenting companies with AI-powered efficiency improvements. Our solutions have saved our customers up to 25% on related departamental costs, substantially decreased their operational risk, and enabled the reallocation of manpower to more pressing issues. We offer end-to-end Machine Learning, Data Science, AI & software development, Strategic Consulting, and Engineering Workshops.
Chambers Bank is a family-owned financial services company that has been serving Arkansas communities since 1930. We are dedicated to providing competitive and innovative products and services and we are committed to the communities we serve. We strive to offer personal service with a hometown feel.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
ADEC Innovations seamlessly delivers fully integrated, cost-effective industry expertise, business process & data management, and software services. Our mission: to ensure we meet your ever-evolving ESG needs and help you improve sustainability performance, gain unprecedented insights, optimize resource use, and drive operational efficiencies. With a global force of over 3,500 employees, our presence spans five continents – Asia, Australia, Europe, Africa and North America. We offer a wide range of solutions and consulting services across multiple fields, providing industry expertise in sustainability, environmental data services, knowledge management, data management, health information, and public-private partnerships. In all these business areas, we focus on aggregating, organizing and giving visibility to data in order to enable client organizations leaders and stakeholders to make informed decisions. Our comprehensive suite of ESG Solutions assist organizations in minimizing negative social and environmental impacts, maximize efficiency, and drive long-term business growth through sustainable profitability and empowered decision making.